Clinical Trials
13
Active:0
Completed:4
Trial Phases
4 Phases
Early Phase 1:1
Phase 1:6
Phase 2:3
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (46.2%)Not Applicable
3 (23.1%)Phase 2
3 (23.1%)Early Phase 1
1 (7.7%)Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Phase 2
Not yet recruiting
- Conditions
- Cirrhotic Ascites
- Interventions
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Protgen Ltd
- Target Recruit Count
- 388
- Registration Number
- NCT06553456
- Locations
- 🇨🇳
Shenzhen Protgen Ltd, Guangdong, Shenzhen, China
Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials
Early Phase 1
Recruiting
- Conditions
- Alzheimer's Disease (AD)
- Interventions
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Protgen Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT06489015
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shang'ai, China
Phase II/III of Recombinant Human Serum Albumin
Phase 2
Completed
- Conditions
- Hepatic Ascites
- Interventions
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Protgen Ltd
- Target Recruit Count
- 92
- Registration Number
- NCT05858853
- Locations
- 🇨🇳
Shenzhen Protgen Ltd, Guangdong, Shenzhen, China
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects
Phase 1
Completed
- Conditions
- Hepatic Ascites
- Interventions
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Protgen Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT05249374
- Locations
- 🇨🇳
Shenzheng Protgen Ltd, Guangdong, Shenzheng, China
Recombinant Human Serum Albumin in Healthy Subjects
Phase 1
Completed
- Conditions
- Hepatic Ascites
- Interventions
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Protgen Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT05179265
- Locations
- 🇨🇳
Shenzheng Protgen Ltd, Guangdong, Shenzheng, China
- Prev
- 1
- 2
- 3
- Next
News
No news found